Article info

Download PDFPDF

Objective measurement and clinical significance of IDO1 protein in hormone receptor-positive breast cancer

Authors

  • Daniel E. Carvajal-Hausdorf Department of PathologyYale School of Medicine New Haven CT USA Anatomía Patológica, Clínica Alemana- Facultad de Medicina Universidad del Desarrollo Vitacura Santiago Chile PubMed articlesGoogle scholar articles
  • Nikita Mani Department of PathologyYale School of Medicine New Haven CT USA Translational Immuno-oncology LaboratoryYale Cancer Center New Haven CT USA PubMed articlesGoogle scholar articles
  • Vamsidhar Velcheti Solid Tumor Oncology, Taussig Cancer Institute, Cleveland Clinic Cleveland OH USA PubMed articlesGoogle scholar articles
  • Kurt A. Schalper Department of PathologyYale School of Medicine New Haven CT USA Anatomía Patológica, Clínica Alemana- Facultad de Medicina Universidad del Desarrollo Vitacura Santiago Chile Translational Immuno-oncology LaboratoryYale Cancer Center New Haven CT USA PubMed articlesGoogle scholar articles
  • David L. Rimm Department of PathologyYale School of Medicine New Haven CT USA PubMed articlesGoogle scholar articles
  1. a dcarvajal{at}alemana.cl
  2. b nikita.mani{at}yale.edu
  3. c velchev{at}ccf.org
  4. d kurt.schalper{at}yale.edu
  5. e david.rimm{at}yale.edu
View Full Text

Citation

Carvajal-Hausdorf DE, Mani N, Velcheti V, et al
Objective measurement and clinical significance of IDO1 protein in hormone receptor-positive breast cancer

Publication history

  • Received May 23, 2017
  • Accepted September 7, 2017
  • First published October 17, 2017.
Online issue publication 
October 17, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.